The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cell Therapy CDMO Services Market 2025 by Company, Regions, Type and Application, Forecast to 2029
Synopsis
The global Cell Therapy CDMO Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cell Therapy CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell Therapy CDMO Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell Therapy CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell Therapy CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell Therapy CDMO Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Therapy CDMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Therapy CDMO Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Medicilon Biopharmaceutical Co., Ltd., Puxin Biomedicine, Porton Bio, Lonza and Catalent, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell Therapy CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cell Therapy CDMO
Cell Therapy CRO
Market segment by Application
Pharmaceutical Company
Research Institute
Market segment by players, this report covers
Shanghai Medicilon Biopharmaceutical Co., Ltd.
Puxin Biomedicine
Porton Bio
Lonza
Catalent
Oxford BioMedica
and meta organisms
GenScript
Huakan Biology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell Therapy CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Therapy CDMO Services, with revenue, gross margin and global market share of Cell Therapy CDMO Services from 2018 to 2023.
Chapter 3, the Cell Therapy CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell Therapy CDMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Therapy CDMO Services.
Chapter 13, to describe Cell Therapy CDMO Services research findings and conclusion.
The global Cell Therapy CDMO Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cell Therapy CDMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell Therapy CDMO Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell Therapy CDMO Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell Therapy CDMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell Therapy CDMO Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Therapy CDMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Therapy CDMO Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Medicilon Biopharmaceutical Co., Ltd., Puxin Biomedicine, Porton Bio, Lonza and Catalent, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell Therapy CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cell Therapy CDMO
Cell Therapy CRO
Market segment by Application
Pharmaceutical Company
Research Institute
Market segment by players, this report covers
Shanghai Medicilon Biopharmaceutical Co., Ltd.
Puxin Biomedicine
Porton Bio
Lonza
Catalent
Oxford BioMedica
and meta organisms
GenScript
Huakan Biology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell Therapy CDMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Therapy CDMO Services, with revenue, gross margin and global market share of Cell Therapy CDMO Services from 2018 to 2023.
Chapter 3, the Cell Therapy CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell Therapy CDMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Therapy CDMO Services.
Chapter 13, to describe Cell Therapy CDMO Services research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Cell Therapy CDMO Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell Therapy CDMO Services by Type
1.3.1 Overview: Global Cell Therapy CDMO Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cell Therapy CDMO Services Consumption Value Market Share by Type in 2022
1.3.3 Cell Therapy CDMO
1.3.4 Cell Therapy CRO
1.4 Global Cell Therapy CDMO Services Market by Application
1.4.1 Overview: Global Cell Therapy CDMO Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Research Institute
1.5 Global Cell Therapy CDMO Services Market Size & Forecast
1.6 Global Cell Therapy CDMO Services Market Size and Forecast by Region
1.6.1 Global Cell Therapy CDMO Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cell Therapy CDMO Services Market Size by Region, (2018-2029)
1.6.3 North America Cell Therapy CDMO Services Market Size and Prospect (2018-2029)
1.6.4 Europe Cell Therapy CDMO Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cell Therapy CDMO Services Market Size and Prospect (2018-2029)
1.6.6 South America Cell Therapy CDMO Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cell Therapy CDMO Services Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Shanghai Medicilon Biopharmaceutical Co., Ltd.
2.1.1 Shanghai Medicilon Biopharmaceutical Co., Ltd. Details
2.1.2 Shanghai Medicilon Biopharmaceutical Co., Ltd. Major Business
2.1.3 Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Product and Solutions
2.1.4 Shanghai Medicilon Biopharmaceutical Co., Ltd. Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Shanghai Medicilon Biopharmaceutical Co., Ltd. Recent Developments and Future Plans
2.2 Puxin Biomedicine
2.2.1 Puxin Biomedicine Details
2.2.2 Puxin Biomedicine Major Business
2.2.3 Puxin Biomedicine Cell Therapy CDMO Services Product and Solutions
2.2.4 Puxin Biomedicine Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Puxin Biomedicine Recent Developments and Future Plans
2.3 Porton Bio
2.3.1 Porton Bio Details
2.3.2 Porton Bio Major Business
2.3.3 Porton Bio Cell Therapy CDMO Services Product and Solutions
2.3.4 Porton Bio Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Porton Bio Recent Developments and Future Plans
2.4 Lonza
2.4.1 Lonza Details
2.4.2 Lonza Major Business
2.4.3 Lonza Cell Therapy CDMO Services Product and Solutions
2.4.4 Lonza Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lonza Recent Developments and Future Plans
2.5 Catalent
2.5.1 Catalent Details
2.5.2 Catalent Major Business
2.5.3 Catalent Cell Therapy CDMO Services Product and Solutions
2.5.4 Catalent Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Catalent Recent Developments and Future Plans
2.6 Oxford BioMedica
2.6.1 Oxford BioMedica Details
2.6.2 Oxford BioMedica Major Business
2.6.3 Oxford BioMedica Cell Therapy CDMO Services Product and Solutions
2.6.4 Oxford BioMedica Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Oxford BioMedica Recent Developments and Future Plans
2.7 and meta organisms
2.7.1 and meta organisms Details
2.7.2 and meta organisms Major Business
2.7.3 and meta organisms Cell Therapy CDMO Services Product and Solutions
2.7.4 and meta organisms Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 and meta organisms Recent Developments and Future Plans
2.8 GenScript
2.8.1 GenScript Details
2.8.2 GenScript Major Business
2.8.3 GenScript Cell Therapy CDMO Services Product and Solutions
2.8.4 GenScript Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 GenScript Recent Developments and Future Plans
2.9 Huakan Biology
2.9.1 Huakan Biology Details
2.9.2 Huakan Biology Major Business
2.9.3 Huakan Biology Cell Therapy CDMO Services Product and Solutions
2.9.4 Huakan Biology Cell Therapy CDMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Huakan Biology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cell Therapy CDMO Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cell Therapy CDMO Services by Company Revenue
3.2.2 Top 3 Cell Therapy CDMO Services Players Market Share in 2022
3.2.3 Top 6 Cell Therapy CDMO Services Players Market Share in 2022
3.3 Cell Therapy CDMO Services Market: Overall Company Footprint Analysis
3.3.1 Cell Therapy CDMO Services Market: Region Footprint
3.3.2 Cell Therapy CDMO Services Market: Company Product Type Footprint
3.3.3 Cell Therapy CDMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Cell Therapy CDMO Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cell Therapy CDMO Services Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Cell Therapy CDMO Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Cell Therapy CDMO Services Market Forecast by Application (2024-2029)
6 North America
6.1 North America Cell Therapy CDMO Services Consumption Value by Type (2018-2029)
6.2 North America Cell Therapy CDMO Services Consumption Value by Application (2018-2029)
6.3 North America Cell Therapy CDMO Services Market Size by Country
6.3.1 North America Cell Therapy CDMO Services Consumption Value by Country (2018-2029)
6.3.2 United States Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
6.3.3 Canada Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Cell Therapy CDMO Services Consumption Value by Type (2018-2029)
7.2 Europe Cell Therapy CDMO Services Consumption Value by Application (2018-2029)
7.3 Europe Cell Therapy CDMO Services Market Size by Country
7.3.1 Europe Cell Therapy CDMO Services Consumption Value by Country (2018-2029)
7.3.2 Germany Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
7.3.3 France Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
7.3.5 Russia Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
7.3.6 Italy Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Cell Therapy CDMO Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cell Therapy CDMO Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cell Therapy CDMO Services Market Size by Region
8.3.1 Asia-Pacific Cell Therapy CDMO Services Consumption Value by Region (2018-2029)
8.3.2 China Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
8.3.3 Japan Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
8.3.5 India Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
8.3.7 Australia Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
9 South America
9.1 South America Cell Therapy CDMO Services Consumption Value by Type (2018-2029)
9.2 South America Cell Therapy CDMO Services Consumption Value by Application (2018-2029)
9.3 South America Cell Therapy CDMO Services Market Size by Country
9.3.1 South America Cell Therapy CDMO Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Cell Therapy CDMO Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cell Therapy CDMO Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cell Therapy CDMO Services Market Size by Country
10.3.1 Middle East & Africa Cell Therapy CDMO Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
10.3.4 UAE Cell Therapy CDMO Services Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Cell Therapy CDMO Services Market Drivers
11.2 Cell Therapy CDMO Services Market Restraints
11.3 Cell Therapy CDMO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Cell Therapy CDMO Services Industry Chain
12.2 Cell Therapy CDMO Services Upstream Analysis
12.3 Cell Therapy CDMO Services Midstream Analysis
12.4 Cell Therapy CDMO Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
